{"id":"https://openalex.org/W2022018760","doi":"https://doi.org/10.1016/s0378-5173(98)00331-7","title":"Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures","display_name":"Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures","alternate_titles":[],"publication_year":1999,"publication_date":"1999-01-15","ids":{"openalex":"https://openalex.org/W2022018760","doi":"https://doi.org/10.1016/s0378-5173(98)00331-7","mag":"2022018760","pmid":"https://pubmed.ncbi.nlm.nih.gov/10205607"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5173(98)00331-7","doi":"https://doi.org/10.1016/s0378-5173(98)00331-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(98)00331-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2022018760"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010826232","display_name":"Cynthia L. Stevenson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"C Stevenson","raw_affiliation_strings":["Glaxo Wellcome, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome, Research Triangle Park, NC 27709, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080539828","display_name":"Patrick Augustijns","orcid":"https://orcid.org/0000-0003-2595-388X","observed_orcids":["https://orcid.org/0000-0003-2595-388X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P F Augustijns","raw_affiliation_strings":["Oligomer Development, Glaxo Wellcome, 5 Moore Drive, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oligomer Development, Glaxo Wellcome, 5 Moore Drive, Research Triangle Park, NC 27709, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041466072","display_name":"R. Wayne Hendren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R W Hendren","raw_affiliation_strings":["Oligomer Development, Glaxo Wellcome, 5 Moore Drive, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oligomer Development, Glaxo Wellcome, 5 Moore Drive, Research Triangle Park, NC 27709, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5010826232"],"corresponding_institution_ids":[],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":5.5549,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.9714258,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"177","issue":"1","first_page":"103","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.25049999356269836,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.25049999356269836,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.2442999929189682,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.23330000042915344,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peptide-permeability","display_name":"peptide permeability","score":0.7570000290870667},{"id":"https://openalex.org/keywords/intestinal-permeability","display_name":"intestinal permeability","score":0.5730000138282776},{"id":"https://openalex.org/keywords/caco-2-cell-monolayers","display_name":"Caco-2 cell monolayers","score":0.949999988079071},{"id":"https://openalex.org/keywords/lc-ms-ms-screening","display_name":"LC-MS/MS screening","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tripeptides","display_name":"tripeptides","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.4180000126361847},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.46399998664855957},{"id":"https://openalex.org/keywords/papp","display_name":"PAPP","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7628383636474609},{"id":"https://openalex.org/C167392928","wikidata":"https://www.wikidata.org/wiki/Q4820777","display_name":"Tripeptide","level":3,"score":0.7280171513557434},{"id":"https://openalex.org/C193176779","wikidata":"https://www.wikidata.org/wiki/Q5016050","display_name":"Caco-2","level":3,"score":0.6737639904022217},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6036890745162964},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.510026752948761},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.4591526389122009},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4340571463108063},{"id":"https://openalex.org/C13935069","wikidata":"https://www.wikidata.org/wiki/Q2157266","display_name":"Oligopeptide","level":3,"score":0.42082667350769043},{"id":"https://openalex.org/C31827203","wikidata":"https://www.wikidata.org/wiki/Q874296","display_name":"Tandem mass spectrometry","level":3,"score":0.4190838932991028},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41220802068710327},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3214639723300934},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10226064920425415},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004848","descriptor_name":"Epithelium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0378-5173(98)00331-7","doi":"https://doi.org/10.1016/s0378-5173(98)00331-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(98)00331-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:10205607","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10205607","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/56807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10205607","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics, vol. 177 (1), (103-115)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W22588564","https://openalex.org/W81070287","https://openalex.org/W156558474","https://openalex.org/W199876327","https://openalex.org/W237605412","https://openalex.org/W264483085","https://openalex.org/W275382298","https://openalex.org/W307292422","https://openalex.org/W1495926848","https://openalex.org/W1566146550","https://openalex.org/W1716352824","https://openalex.org/W1968675652","https://openalex.org/W1979196526","https://openalex.org/W1981978551","https://openalex.org/W1996912564","https://openalex.org/W2014323250","https://openalex.org/W2015863698","https://openalex.org/W2031698690","https://openalex.org/W2040356210","https://openalex.org/W2041719513","https://openalex.org/W2051732589","https://openalex.org/W2065236789","https://openalex.org/W2073025812","https://openalex.org/W2082406042","https://openalex.org/W2088855126","https://openalex.org/W2089219221","https://openalex.org/W2092836618","https://openalex.org/W2410766617","https://openalex.org/W2417625787","https://openalex.org/W2419324671","https://openalex.org/W2474933148"],"related_works":["https://openalex.org/W2526920118","https://openalex.org/W180767550","https://openalex.org/W2077957449","https://openalex.org/W2037347330","https://openalex.org/W199876327","https://openalex.org/W2012964175","https://openalex.org/W2386933100","https://openalex.org/W2749452111","https://openalex.org/W2071464010","https://openalex.org/W187487230"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2022018760","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
